港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

药捷安康-B

196.400

-7.800-3.82%

成交量：54.56万

成交额：1.08亿

市值：779.71亿

市盈率：-249.60

高：206.000

开：203.000

低：194.500

收：204.200

52周最高：679.500

52周最低：20.200

股本：3.97亿

香港流通股本：3.02亿

量比：0.36

换手率：0.18%

股息：- -

股息率：- -

每股收益(LYR):-0.787

净资产收益率：-39.08%

总资产收益率：-21.10%

市净率：122.47

市盈率(LYR):-249.60

市销率: - -

数据加载中...

总览公司新闻资讯公告

药捷安康-B跌2.06% 股价跌破200港元大关

多家银行出台方案优化供给金融精准服务新型工业化

药企赴港IPO火爆，半个月8家递表，基石投资者“快看不过来了”

药捷安康-B11月13日主力净流出409.9万元散户资金买入

药捷安康-B盘中异动大幅拉升4.77%报224.000港元

药捷安康-B11月11日主力净流出704.0万元散户资金买入

香港IPO集资额重登全球之巅惠理创始人谢清海剖析背后的“赢家密码”

智通港股通资金流向统计(T+2)|11月10日

生物医药股普跌药捷安康-B(02617)跌5.34%

港股综述｜三大指数午后回暖！航空股全天强势，锂电池、电力设备股强势拉升

老虎资讯综合

药捷安康(2617.HK)尾盘拉升涨超21%，与Neurocrine达成项目合作

药捷安康-B11月05日主力净流入4018.6万元散户资金抛售

港股药捷安康-B涨幅扩大至20%

南方财经网

部分港股医药股反弹药捷安康涨近5%

每日经济新闻

创新药资本调整三个月，谁在改变？

CNS专题1：抗抑郁新靶点国内有哪些映射？

石药集团执行董事被罚500万元，海思科1类新药获批临床，药捷安康拿下8.8亿美元BD合作，百奥泰3.3亿元成立生物药业公司

药捷安康宣布达成重磅授权合作！东阳光药新药IND……

医药经济报

一款临床前国产新药超8亿美元出海，有何潜力？

药捷安康-B11月03日获主力加仓419.0万元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02617/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":196.4,"timestamp":1763366893755,"preClose":204.2,"halted":0,"volume":545610,"delay":0,"floatShares":301666673,"shares":397000000,"eps":-0.7868719582099297,"marketStatus":"未开盘","change":-7.8,"latestTime":"11-17 16:08:13","open":203,"high":206,"low":194.5,"amount":107768274,"amplitude":0.056317,"askPrice":196.4,"askSize":4000,"bidPrice":196.3,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.6788295513164337,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":0,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":204.2,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"volumeRatio":0.362647,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-21.10%","roe":"-39.08%","lyrEps":-0.786872,"volumeRatio":0.362647,"shares":397000000,"dividePrice":0,"high":206,"amplitude":0.056317,"preClose":204.2,"low":194.5,"week52Low":20.2,"pbRate":"122.47","week52High":679.5,"institutionHeld":0,"latestPrice":196.4,"committee":-0.777778,"eps":-0.7868719582099297,"divideRate":0,"volume":545610,"delay":0,"ttmEps":-0.6788295513164337,"open":203,"prevYearClose":13.15,"prevWeekClose":204.2,"prevMonthClose":183.8,"prevQuarterClose":141.2,"fiveDayClose":233,"twentyDayClose":203,"sixtyDayClose":51.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-11-14","current":-289.313297,"percent":0.079208,"low":-380.446233,"twenty":-262.893893,"median":-70.289151,"eighty":-42.482614,"high":-17.403134,"avg":-136.990218,"sd":107.716882,"marketCap":81046496658},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-24","current":-293.038662,"twenty":-206.454369,"median":-63.574223,"eighty":-42.029097,"marketCap":75807447903},{"date":"2025-10-31","current":-281.572204,"twenty":-212.338922,"median":-65.741367,"eighty":-42.067733,"marketCap":72949784945},{"date":"2025-11-07","current":-338.772318,"twenty":-240.199465,"median":-68.232426,"eighty":-42.195906,"marketCap":87714376893},{"date":"2025-11-14","current":-312.135011,"twenty":-262.893893,"median":-70.289151,"eighty":-42.482614,"marketCap":81046496658}],"updateTime":1763395922913},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584969641","title":"药捷安康-B跌2.06% 股价跌破200港元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2584969641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584969641?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 09:44","pubTimestamp":1763343895,"startTime":"0","endTime":"0","summary":"2025年11月17日早盘09时44分，药捷安康-B股票出现异动，股价急速跳水2.06%。截至发稿，该股报200.000港元/股，成交量5.9万股，换手率0.02%，振幅3.43%。资金方面，该股资金流入172.68万港元，流出554.89万港元。药捷安康-B股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，来凯医药-B、派格生物医药-B、云康集团涨幅较大，振幅较大的相关个股有派格生物医药-B、MIRXES-B、来凯医药-B，振幅分别为27.98%、11.60%、10.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117094455976dc6f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117094455976dc6f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2584695843","title":"多家银行出台方案优化供给 金融精准服务新型工业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2584695843","media":"经济日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584695843?lang=zh_cn&edition=fundamental","pubTime":"2025-11-16 09:32","pubTimestamp":1763256720,"startTime":"0","endTime":"0","summary":"近日，中国建设银行、中国银行等发布落实《意见》要求的相关实施方案，进一步细化与新型工业化相适应的金融机制，全面支持我国新型工业化深入发展。截至今年6月末，中国银行工业领域供应链融资余额及科技型企业贷款余额双双突破2.3万亿元，保持较快增长势头。中国光大银行推出支持新型工业化金融服务方案，通过40项具体工作举措，全面支持新型工业化深入推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116093421a6fc4400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116093421a6fc4400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2583363717","title":"药企赴港IPO火爆，半个月8家递表，基石投资者“快看不过来了”","url":"https://stock-news.laohu8.com/highlight/detail?id=2583363717","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583363717?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 16:43","pubTimestamp":1763196217,"startTime":"0","endTime":"0","summary":"“我们正在中国香港进行IPO路演，但这段时间药企扎堆申报港股IPO，已形成了‘堰塞湖’，基石投资者和锚定投资者都快看不过来了，我们遭遇路演排队。”有赴港IPO药企人士对第一财经记者透露。今年以来，港股医药二级市场的复苏，提振了企业们IPO融资热情。根据Choice金融终端数据，截至11月14日，港股的医疗保健板块今年累计迎来了23家企业成功上市，而去年同期仅有8家企业上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"eastmoney_highlight","url":"http://hk.eastmoney.com/news/11792,202511153565388760.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.eastmoney.com/news/11792,202511153565388760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["LU0594300179.USD","LU1934453819.USD","300760","LU1023057109.AUD","LU2097828714.EUR","LU0405327494.USD","LU1580142542.USD","LU2153592121.USD","IE0031814852.USD","LU2097828805.USD","HK0000252160.HKD","LU0359201612.USD","688506","LU1979443071.USD","LU2580892862.HKD","LU1328615791.USD","LU1688375341.USD","LU1720050803.USD","LU2153591404.USD","02595","LU2148510915.USD","LU1146622755.USD","09939","GIC","09606","LU1781817850.SGD","BK1515","HK0000500386.USD","SGXZ81163826.USD","02617","LU1734074674.USD","LU0605514214.HKD","LU2213484517.USD","HK0000252152.HKD","LU1064130708.USD","LU2097828474.EUR","LU1655091616.SGD","BK4104","SGXZ49509284.SGD","09887","02591","IE00B29SXG58.USD","LU1064131003.USD","LU0572944931.SGD","300558","02615","BK0196","LU0823426308.USD","LU1997244956.HKD","600276"],"gpt_icon":0},{"id":"2583523515","title":"药捷安康-B11月13日主力净流出409.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2583523515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583523515?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 16:15","pubTimestamp":1763021705,"startTime":"0","endTime":"0","summary":"11月13日, 药捷安康-B股价跌1.52%，报收207.00元，成交金额2.6亿元，换手率0.41%，振幅6.57%，量比0.51。药捷安康-B今日主力资金净流出409.9万元，上一交易日主力净流入29.8万元。该股近5个交易日下跌5.81%，主力资金累计净流入1684.0万元；近20日主力资金累计净流入7651.5万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113161516a6f67580&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113161516a6f67580&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2582942317","title":"药捷安康-B盘中异动 大幅拉升4.77%报224.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582942317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582942317?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 09:40","pubTimestamp":1762911658,"startTime":"0","endTime":"0","summary":"2025年11月12日早盘09时40分，药捷安康-B股票出现异动，股价急速拉升4.77%。截至发稿，该股报224.000港元/股，成交量23.8628万股，换手率0.08%，振幅5.14%。资金方面，该股资金流入1984.02万港元，流出1475.2万港元。药捷安康-B股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，中生北控生物科技、药捷安康-B、百济神州涨幅较大，振幅较大的相关个股有荣昌生物、来凯医药-B、药捷安康-B，振幅分别为8.11%、7.77%、5.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111209405897639ba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111209405897639ba5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2582317920","title":"药捷安康-B11月11日主力净流出704.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2582317920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582317920?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 16:15","pubTimestamp":1762848955,"startTime":"0","endTime":"0","summary":"11月11日, 药捷安康-B股价跌8.24%，报收213.80元，成交金额3.3亿元，换手率0.50%，振幅10.21%，量比0.51。药捷安康-B今日主力资金净流出704.0万元，上一交易日主力净流入1984.6万元。该股近5个交易日上涨18.12%，主力资金累计净流入5642.6万元；近20日主力资金累计净流入8031.5万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111162149976214a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111162149976214a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2582844837","title":"香港IPO集资额重登全球之巅 惠理创始人谢清海剖析背后的“赢家密码”","url":"https://stock-news.laohu8.com/highlight/detail?id=2582844837","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582844837?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 14:01","pubTimestamp":1762754460,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，多只重磅新股在港交所上市，推动香港新股市场今年表现亮丽，重夺首次公开发行集资额冠军豪无悬念。谢清海称，将香港建设、巩固和发展成为国际金融中心，不仅对香港本身至关重要，对国家同样重要。香港行政长官李家超上周出席国际金融领袖投资峰会主峰会时表示，香港今年首10个月，新股集资额全球排名第一，期内共有80宗IPO，集资额超过260亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1807302812.USD","BK1161","HEXmain","BK1156","IPO","BK1610","02617","BK1116","LU1993786604.SGD","00806","BK1198","LU1960683339.HKD"],"gpt_icon":1},{"id":"2582252819","title":"智通港股通资金流向统计(T+2)|11月10日","url":"https://stock-news.laohu8.com/highlight/detail?id=2582252819","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582252819?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 07:31","pubTimestamp":1762731060,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，11月5日,南方恒生科技、阿里巴巴-W、小米集团-W南向资金净流入金额位列市场前三，分别净流入12.86 亿、8.85 亿、6.50 亿华虹半导体、中芯国际、哔哩哔哩-W南向资金净流出金额位列市场前三，分别净流出-6.42 亿、-5.05 亿、-1.88 亿在净流入比方面，青岛银行、中国通号、大唐新能源以83.58%、56.27%、55.14%位列市场前三。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00168","81024","03033","09636","02039","02382","01055","IE00B3M56506.USD","03866","02601","00548","02273","02899","00667","00883","01398","06869","09988","02192","09626","00966","00639","00257","MCHmain","02419","00990","HXXD.SI","01798","03403","00991","02460","81810","03143","89988","KSTmain","00308","XIACY","00939","HBBD.SI","03969","00763","02828","02800","80883","02617","01810"],"gpt_icon":1},{"id":"2581080038","title":"生物医药股普跌 药捷安康-B(02617)跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581080038","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581080038?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 10:07","pubTimestamp":1762394826,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药股普跌，药捷安康-B 跌5.34%，科伦博泰生物-B跌5.20%，康诺亚-B跌4.52%，药师帮跌4.46%，映恩生物-B跌3.95%，佰泽医疗跌3.69%，乐普生物-B跌3.32%，再鼎医药跌3.16%，脑动极光-B跌2.96%，亚盛医药-B跌2.75%。交银国际表示，医药行业板块3Q25业绩呈现边际复苏态势，其中与创新产业链关联紧密的化药/生物药公司和CXO板块表现较优，集采影响逐步出清的子板块也有改善迹象。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1969129","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09885","BK1197","BK1189","LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD","06855","09606","LU0196878994.USD","BK1161","06681","02617","LU2488822045.USD","399441","09688","02162","BK1588","HK0000252160.HKD","BK1574","06990","02609","02157","BK1587","BK1209","161726","BK1583"],"gpt_icon":0},{"id":"1138049857","title":"港股综述｜三大指数午后回暖！航空股全天强势，锂电池、电力设备股强势拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=1138049857","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138049857?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:33","pubTimestamp":1762331602,"startTime":"0","endTime":"0","summary":"恒指微跌0.07%，航空股全天维持强势，锂电池、电力设备股强势拉升11月5日，午后市场明显回暖，恒生指数、国企指数一度转涨，最终分别收跌0.07%及0.11%，恒指在26000点附近反复震荡，恒生科技指数跌0.56%相对最弱，三大指数均呈现低开高走行情。A股行情A股收评：低开高走！全市场成交额1.89万亿元，较前一交易日缩量441亿元，近3400股上涨。","market":"hk","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f0e8db0f06f95058464db3c9adf61f49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSI","HSTECH","02617"],"gpt_icon":0},{"id":"2581495087","title":"药捷安康(2617.HK)尾盘拉升涨超21%，与Neurocrine达成项目合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2581495087","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581495087?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:17","pubTimestamp":1762330622,"startTime":"0","endTime":"0","summary":"药捷安康-B尾盘拉升涨超21%。药捷安康近日公告，Neurocrine与本公司订立一项付特许权使用费的专利转让及研究合作协议，以开发NLRP3抑制剂，用于治疗多种疾病。根据该协议，公司将有权获得预付款，并且根据Neurocrine的开发和商业化进展，公司可能会收到与研发里程碑和销售里程碑相关的进一步里程碑付款，该协议的总潜在价值为8.815亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251105/31769637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2581246817","title":"药捷安康-B11月05日主力净流入4018.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2581246817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581246817?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:15","pubTimestamp":1762330545,"startTime":"0","endTime":"0","summary":"11月05日, 药捷安康-B股价涨26.30%，报收228.60元，成交金额9.6亿元，换手率1.58%，振幅27.96%，量比2.72。药捷安康-B今日主力资金净流入4018.6万元，上一交易日主力净流出181.7万元。该股近5个交易日上涨24.58%，主力资金累计净流入4974.8万元；近20日主力资金累计净流入6407.5万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110516200894f0788e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110516200894f0788e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2581749954","title":"港股药捷安康-B涨幅扩大至20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581749954","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581749954?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:12","pubTimestamp":1762330336,"startTime":"0","endTime":"0","summary":"港股药捷安康-B涨幅扩大至20%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511053555881526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2581790003","title":"部分港股医药股反弹 药捷安康涨近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581790003","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581790003?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 09:59","pubTimestamp":1762307949,"startTime":"0","endTime":"0","summary":"每经AI快讯，11月5日，截至发稿，药捷安康-B(02617.HK)涨4.97%、北海康成-B(01228.HK)涨2.70%、中国抗体-B(03681.HK)涨2.48%、康诺亚-B(02162.HK)涨2.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511053555629975.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511053555629975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2581764942","title":"创新药资本调整三个月，谁在改变？","url":"https://stock-news.laohu8.com/highlight/detail?id=2581764942","media":"研发客","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581764942?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 05:00","pubTimestamp":1762290042,"startTime":"0","endTime":"0","summary":"研发客根据Choice数据统计整理可见，56家生物医药公司中，21家公司在过去三个月实现上涨，其余35家公司均出现不同程度下跌。其中，药捷安康的势头最猛，过去三个月的区间涨幅达384.32%。公司预计NDA将于今年三季度获批，不过显然尚未兑现。信达生物则在最新的公告中披露，2025年第三季度，公司产品收入为超33亿元人民币，同比增长40%。震荡调整之下管线推进速度如何过去三个月，创新药板块跌幅最大的是中国抗体，下跌49.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105050335a6e143cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105050335a6e143cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","LU2488822045.USD","06978","BK1589","LU2097828714.EUR","09926","02142","LU2097828805.USD","LU2242644610.SGD","LU1969619763.USD","LU2097828557.USD","LU2097828474.EUR","BK1161","BK1583","LU2328871848.SGD","LU2097828631.EUR","LU0455707207.USD","02617","BK1574","LU0502904849.HKD"],"gpt_icon":0},{"id":"2581590745","title":"CNS专题1：抗抑郁新靶点 国内有哪些映射？","url":"https://stock-news.laohu8.com/highlight/detail?id=2581590745","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581590745?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 00:00","pubTimestamp":1762272000,"startTime":"0","endTime":"0","summary":"创新药CNS系列专题：抗抑郁市场潜力巨大，众多新靶点即将迎来催化：抑郁市场空间庞大：根据2021年全球疾病负担研究，全球抑郁症发病数超3.5亿人，其中国内抑郁症患者超过9000万人，患者疾病负担巨大。新一代抗抑郁药的研发需在“快速起效”与“长期安全”间寻求平衡。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110515274694f05d0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110515274694f05d0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0561508036.HKD","09926","IE00B543WZ88.USD","LU2476274308.USD","LU2488822045.USD","IE00B5MMRT66.SGD","BK1574","LU0348767384.USD","LU0348766576.USD","02696","06978","LU0417516738.SGD","LU0634319403.HKD","LU2399975544.HKD","LU0348825331.USD","BK1161","LU0348735423.USD","09887","LU0540923850.HKD","LU0348784397.USD","IE00BPRC5H50.USD","01167","LU0348783233.USD","01801","LU1720050803.USD","02617","LU0417516902.SGD","LU2778985437.USD","LU0348827113.USD","LU1794554557.SGD","LU2476274720.SGD","LU0417516571.SGD","LU1961090484.USD"],"gpt_icon":0},{"id":"2580246423","title":"石药集团执行董事被罚500万元，海思科1类新药获批临床，药捷安康拿下8.8亿美元BD合作，百奥泰3.3亿元成立生物药业公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2580246423","media":"谈医说药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580246423?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 22:40","pubTimestamp":1762180839,"startTime":"0","endTime":"0","summary":"截至目前，瑞维鲁胺片相关项目累计研发投入约6.93亿元。证监会经调查认为，潘卫东在新诺威拟与石药百克进行重组交易公开前，知悉内幕信息，利用石药集团全资附属公司恩必普的证券账户，买入新诺威274.258万股，买入金额为9998.88万元，构成内幕交易。证监会责令潘卫东依法处理非法持有的证券，并处罚款500万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104010706a6de5f98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104010706a6de5f98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226287529.USD","SG9999004220.SGD","02617","LU1951186391.HKD","LU0880133367.SGD","02005","LU1328277881.USD","IE0008369823.USD","LU1008478684.HKD","LU0501845795.SGD","BK1521","LU1226287875.USD","IE00B5MMRT66.SGD","LU1993786604.SGD","BK1161","LU0314109678.HKD","IE00B543WZ88.USD","LU0067412154.USD","LU0315179316.USD","LU1152091168.USD","LU1226287792.SGD","LU1226288170.HKD","LU1960683339.HKD","LU1807302812.USD","LU0072913022.USD","IE00BZ08YS42.EUR","LU2460026573.USD","IE0008368742.USD","BK1515","LU1813983027.USD","LU1226288253.USD","IE00B031HY20.USD","LU0140636845.USD","BK1191","LU2039709279.SGD","IE00BZ08YR35.GBP","LU0326950275.SGD","IE00BZ08YT58.USD","LU1152091754.HKD","01093"],"gpt_icon":0},{"id":"2580478370","title":"药捷安康宣布达成重磅授权合作！东阳光药新药IND……","url":"https://stock-news.laohu8.com/highlight/detail?id=2580478370","media":"医药经济报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580478370?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 19:59","pubTimestamp":1762171149,"startTime":"0","endTime":"0","summary":"药捷安康宣布达成一项超8亿美元授权合作11月3日，药捷安康（南京）科技股份有限公司发布公告宣布，公司与Neurocrine Biosciences, Inc.订立一项付特许权使用费的专利转让及研究合作协议，以开发NLRP3抑制剂，用于治疗多种疾病。东阳光药抗乙肝siRNA新药获批临床11月1日，国家药品监督管理局药品审评中心官网最新公开显示，东阳光药申报的1类新药HECN30227获批临床，拟定适应症为慢性乙型肝炎。根据东阳光药公开资料，这是其自主研发的siRNA疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103230902a4857549&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103230902a4857549&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1191","06887","BK1161"],"gpt_icon":1},{"id":"2580247388","title":"一款临床前国产新药超8亿美元出海， 有何潜力？","url":"https://stock-news.laohu8.com/highlight/detail?id=2580247388","media":"医药时间","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580247388?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 17:14","pubTimestamp":1762161272,"startTime":"0","endTime":"0","summary":"11 月 3 日，药捷安康宣布与 Neurocrine Biosciences 签署一项专利转让及研究合作协议。值得注意的是，大量的临床前及临床研究已表明，NLRP3 炎性小体是肥胖症的关键治疗靶点。作为一种新型、高效、选择性的 NLRP3 抑制剂，TT-02332 可有效抑制过度炎症，并具有良好的剂量依赖性。体外试验结果表明，TT-02332 对人巨噬细胞系 THP-1 及人全血中的 NLRP3 炎症小体具有强效抑制作用，突显了其潜在的临床疗效。此外，TT-02332 表现出较高的选择性，对 NLRP3 的选择性较其他炎症小体超过 1000 倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103213611a6de0b1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103213611a6de0b1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2580224736","title":"药捷安康-B11月03日获主力加仓419.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580224736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580224736?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 16:15","pubTimestamp":1762157723,"startTime":"0","endTime":"0","summary":"11月03日, 药捷安康-B股价涨2.99%，报收189.30元，成交金额3.3亿元，换手率0.57%，振幅6.53%，量比0.74。药捷安康-B今日主力资金净流入419.0万元，上一交易日主力净流入719.0万元。该股近5个交易日下跌0.89%，主力资金累计净流入1138.0万元；近20日主力资金累计净流入2570.6万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103161701a6dd5e2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103161701a6dd5e2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":190,"code":"91000000","status":"200"}]}}